Last quarter (Q3 2025), Rallybio's total revenue was $212.00K, a decrease of -29.10% from the same quarter last year. In Q3, Rallybio's net income was $16.02M. See Rallybio’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 636.00K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 636.00K	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Expenses	$ 61.13M	$ 78.93M	$ 67.88M	$ 45.65M	$ 25.30M
Depreciation and Amortization	$ 131.00K	$ 150.00K	$ 167.00K	$ 109.00K	$ 62.00K
EBITDA	$ -60.37M	$ -78.78M	$ -67.72M	$ -45.39M	$ -25.24M
Operating Income	$ -60.50M	$ -78.93M	$ -67.88M	$ -45.65M	$ -25.30M
Other Income/Expenses	$ 2.72M	$ 4.37M	$ 155.00K	$ -1.36M	$ -1.16M
Pretax Income	$ -57.77M	$ -74.56M	$ -67.73M	$ -47.01M	$ -26.46M
Net Income	$ -57.77M	$ -74.56M	$ -66.65M	$ -47.01M	$ -26.45M
Per Share Metrics
Basic EPS	$ -1.33	$ -1.84	$ -2.09	$ -1.46	$ -1.19
Diluted EPS	$ -1.33	$ -1.84	$ -2.09	$ -1.46	$ -1.19
Weighted Average Shares Outstanding	43.55M	40.45M	31.82M	32.13M	22.24M
Weighted Average Shares Outstanding (Diluted)	43.55M	40.45M	31.82M	32.13M	22.24M

Currency in USD

Rallybio Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing